744 Assessment of Safety and Immunologic Activity of Nemvaleukin Alfa in Patients with Advanced Solid Tumors Treated with Less Frequent Intravenous Dosing (ARTISTRY-3)
Regular and Young Investigator Award Abstracts（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined